AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit

FibroGen is cracking down on former employees accused of trade secret theft. The company filed a lawsuit in the U.S. District Court in the Northern District of California.

The company slapped former employees Dong Liu, Ph.D., and Shaojiang Deng, Ph.D., with the suit to ask that the defendants stop their use of the propriety information and correct their patents to list the true owner, which is FibroGen, the company alleges. The company is also seeking compensation and wants the former employees to give up profits made from the patents they “wrongfully” claim.